Science
Al-Ola Abdallah: Incidence and Risk Factors for Carfilzomib-Induced Cardiovascular Toxicity
Al-Ola Abdallah/ LinkedIn

Al-Ola Abdallah: Incidence and Risk Factors for Carfilzomib-Induced Cardiovascular Toxicity

Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared on LinkedIn:

”Title: Incidence and Associated Risk Factors in the Development of Carfilzomib-Induced Cardiovascular Toxicity

Authors: Noor Lad, Jayda Esplund, Dennis Grauer, Shebli Atrash, Prerna Mewawalla, Tejaswi Gadela, Charles Porter, Muhammad Mushtaq, Jeries Kort, Donald C. Moore, Al-Ola Abdallah, Zahra Mahmoudjafari, Jordan Snyder

Read the full Article.”

Al-Ola Abdallah: Incidence and Risk Factors for Carfilzomib-Induced Cardiovascular Toxicity

Other articles about Cardiooncology on OncoDaily.

Al-Ola Abdallah cancer CardioOncology Charles Porter Dennis Grauer Donald C. Moore Jayda Esplund Jeries Kort Jordan Snyder Muhammad Mushtaq Noor Lad OncoDaily Oncology Prerna Mewawalla Shebli Atrash Tejaswi Gadela Zahra Mahmoudjafari